LAURA CORWIN: Open Payments
NPI 1861862112 · MILL CREEK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 106 payments from 15 companies in 2025. Trend: 2023 $1,287 · 2024 $1,470 · 2025 $1,863
Food & beverage: $1,863
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 19 | $331 |
| Arcutis Biotherapeutics, Inc. | 14 | $248 |
| Janssen Biotech, Inc. | 21 | $239 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $167 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| Lilly USA, LLC | 7 | $106 |
| ABBVIE INC. | 4 | $98 |
| GENZYME CORPORATION | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| UCB, Inc. | 4 | $91 |
Products named: OPZELURA, Zoryve, TREMFYA, DUPIXENT, ILUMYA, TALTZ, Bimzelx, COSENTYX.
Industry payments across WA — which companies pay providers there.
